122 related articles for article (PubMed ID: 14752538)
1. Buteyko Breathing Technique for asthma: an effective intervention.
McHugh P; Aitcheson F; Duncan B; Houghton F
N Z Med J; 2003 Dec; 116(1187):U710. PubMed ID: 14752538
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial of the Buteyko technique as an adjunct to conventional management of asthma.
Cowie RL; Conley DP; Underwood MF; Reader PG
Respir Med; 2008 May; 102(5):726-32. PubMed ID: 18249107
[TBL] [Abstract][Full Text] [Related]
3. Buteyko breathing techniques in asthma: a blinded randomised controlled trial.
Bowler SD; Green A; Mitchell CA
Med J Aust; 1998 Dec 7-21; 169(11-12):575-8. PubMed ID: 9887897
[TBL] [Abstract][Full Text] [Related]
4. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
5. A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma.
Ige OM; Sogaolu OM
Afr J Med Med Sci; 2004 Jun; 33(2):155-60. PubMed ID: 15565935
[TBL] [Abstract][Full Text] [Related]
6. Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma.
Wang Y; Wang CZ; Lin KX; Qian GS; Zhuo WL; Li SP; Zhao ZQ; Liao XQ; Song YX
Respirology; 2005 Mar; 10(2):189-95. PubMed ID: 15823184
[TBL] [Abstract][Full Text] [Related]
7. Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma.
Bousquet J; Aubier M; Sastre J; Izquierdo JL; Adler LM; Hofbauer P; Rost KD; Harnest U; Kroemer B; Albrecht A; Bredenbröker D
Allergy; 2006 Jan; 61(1):72-8. PubMed ID: 16364159
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
[TBL] [Abstract][Full Text] [Related]
9. Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial.
Huang LH; Shyur SD; Wen DC; Chang YC; Ma YC; Lin SC; Wu WC; Wu JY
Acta Paediatr Taiwan; 2007; 48(5):257-62. PubMed ID: 18254574
[TBL] [Abstract][Full Text] [Related]
10. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
[TBL] [Abstract][Full Text] [Related]
11. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
Lu S; Liu N; Dass SB; Reiss TF
J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
[TBL] [Abstract][Full Text] [Related]
12. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
[TBL] [Abstract][Full Text] [Related]
13. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
[TBL] [Abstract][Full Text] [Related]
14. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a positive expiratory pressure device in conjunction with beta2-agonist nebulization therapy for bronchial asthma.
Tsai CF; Tsai JJ
J Microbiol Immunol Infect; 2001 Jun; 34(2):92-6. PubMed ID: 11456366
[TBL] [Abstract][Full Text] [Related]
16. [Study of personal best value of peak expiratory flow in patients with asthma--comparison of the highest value of daily PEF under good control and the highest value of daily PEF obtained after using repeated inhaled beta2-agonist during high-dose inhaled steroid treatment].
Watanabe N; Makino S; Kihara N; Fukuda T
Arerugi; 2008 Dec; 57(12):1284-92. PubMed ID: 19169083
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
18. The Buteyko breathing technique for asthma: a review.
Bruton A; Lewith GT
Complement Ther Med; 2005 Mar; 13(1):41-6. PubMed ID: 15907677
[TBL] [Abstract][Full Text] [Related]
19. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways?
Boulet LP
Respir Med; 2006 Mar; 100(3):496-502. PubMed ID: 16039107
[TBL] [Abstract][Full Text] [Related]
20. Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial.
Chen YZ; Busse WW; Pedersen S; Tan W; Lamm CJ; O'Byrne PM
Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():7-13. PubMed ID: 16573703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
